$Rocket Lab USA, Inc.(RKLB)$ If you’re hunting for something a bit more speculative, check out Rocket Lab,They’re actively launching satellites and expanding fast.
$Constellation Energy Corp(CEG)$ AI’s power hunger is real. $Vistra Energy Corp.(VST)$ just dropped $1.9B to buy 7 natural gas plants, straight-up betting on fossil fuels to meet AI’s massive demand. Don’t sleep on traditional energy,it’s becoming a key piece in the AI puzzle. Names like CEG are looking more interesting by the day.
$Zai Lab Ltd(ZLAB)$ Big win for ZLAB,no doubt this is major news. Drug 1310 just scored orphan drug + fast track approval = 7 years of exclusivity and a faster launch path. That puts them ahead of $INNOVENT BIO(01801)$ and $HENGRUI PHARMA(01276)$ , who’ve already licensed out. Zai Lab’s still holding it tight… curious to see their next move. Could get interesting.
$Coinbase Global, Inc.(COIN)$ is seriously growing on me. Stablecoins are quietly becoming a new backbone for the dollar,and a fresh source of demand for U.S. Treasuries. Tether’s already one of the major holders. COIN’s USDC issuance jumped from $10B to over $60B in just two years. Last quarter, nearly half their revenue came from USDC and subscriptions,that’s no joke.And don’t forget Citi’s call: stablecoins could hit $1.6T–$3.7T by 2030. If that plays out, COIN is sitting right at the heart of the action.
$HUA HONG SEMI(01347)$ HK semis are pushing up against the tide,Huahong Semi dropped four days straight last week, but finally bounced yesterday! Let’s see what kind of show it puts on this week and next.
$HUTCHMED(00013)$ is rock-solid financially, loaded with cash,no worries there. Honestly, buying now feels like getting a cheap call option for free. Solid deal.
$Moderna, Inc.(MRNA)$ saw strong big-money buying last Friday’s close. I’m holding tight this week. If the monthly candle turns green, my confidence will jump even higher,feels like good things ahead!
$Direxion Daily S&P Biotech Bull 3x Shares(LABU)$ Add more positions! You will be sorry if you don't add more positions at this price. Compared with the S&P 500 $S&P 500(.SPX)$ , the valuation of bio-pharmaceuticals is now very cheap, the same level as when the market was most uncertain. Those who understand know that this is an opportunity to pick up a bargain! There are several key catalysts on the way this week. I feel that this wave is about to take off. Wait for the rise
$TAL Education Group(TAL)$ , it's so hot tonight, it's definitely a Chinese stock star!Everyone is selling like crazy and making a lot of money, are there any brothers who have rushed in? How much have you made? Tell us now!
$Novo-Nordisk A/S(NVO)$ ’s CEO getting fired was a wake-up call,no matter how ahead you are, if you stop strengthening your moat, someone will catch up. That’s why I care more and more about who's running the company. Buffett wasn’t kidding when he said: it’s all about the moat.
AI Hype vs Reality: Why Palo Alto Needs to Quantify AI's ARR Impact Now
$Palo Alto Networks(PANW)$ delivered a "healthy but not spectacular" earnings report, with revenue and EPS beat but slowing billings, continued long-term structural optimization, and a lack of clear short-term catalysts.Investors need to look beyond quarterly volatility to ARR platformization trends and AI commercialization prospects.In the coming quarters, the company will need to further quantify the impact of AI in its earnings reports and increase the conversion rate of its platform customers in order to support the current valuation to enter a new cycle of upward revisions.Performance and Market FeedbackRevenue: $2.29B (+15% YoY), slightly ahead of expectations (consensus $2.27B)EPS (Non-GAAP): $1.32, beating estimates ($1.25 est.)Billings (B
I find the recent scrutiny surrounding Apple's $Apple(AAPL)$ AI partnership with Alibaba $Alibaba(09988)$ quite concerning, especially given the potential impact on iPhone sales in China. The post highlights how U.S. White House and congressional officials have been reviewing this deal, as Apple plans to integrate its Apple Intelligence features with Alibaba's technology in China. This collaboration is critical for Apple, considering China accounts for a significant portion of its revenue, and I worry that this scrutiny could delay the launch of these AI features. If the launch is hindered, I fear it might exacerbate th
$Xiaomi HK SDR 2to1(HXXD.SI)$ This is one of the New Lovers 💕😘 that I just get to know 😻$Xiaomi HK SDR 2to1(HXXD.SI)$ .... Has been observing her from afar for a while until recently pick up the courage to ask for a date 🌹...So far the relationship is blooming with some result's [USD] [USD] [USD] . I will be Holding on to this lover 💕 for a longer period 💘. (Bullish MAs are lining up 😉😜).
🎁 Bet on Xpeng Stock Movement and Win Tiger Coins!
Hi, Tigers!Welcome to Daily Discussion! This is the place for you to share your trading ideas and win coins!Click here to join the Topic & Win coins >>[Rewards]We will reward you with 50 Tiger Coins when you share your knowledge about stocks and markets here, depending on quality and originality.[Winners Announcement:20 May]1.Here are the 7 Tigers whose post has the best quality & interaction yesterday:Congratulations on being offered 50 Tiger Coins!Ctrip’s
Ohmyhome Ltd (OMH), a Singapore-based real estate technology company, specializes in providing a one-stop platform for property transactions, including buying, selling, renting, and renovation services. Listed on NASDAQ under the ticker OMH, the stock has garnered attention from investors. This analysis is based on the stock’s performance as of May 20, 2025 (closing price $2.21, up 5.74% daily), its daily chart trends, and recent news developments. Price Performance and Technical Analysis The daily chart reveals significant volatility for OMH between April and May 2025. In early April, the stock fell sharply from a high of $3.79 to a low of $1.47, a decline of over 60%, likely influenced by market sentiment toward the real estate sector or company-specific challenges. However, in early May
Markets are processing a wave of contradictions: Tax debates dominate U.S. headlines, but history is clear: only sustained economic growth can materially reduce deficits. 30-year Treasury yields are approaching 5%, reflecting long-term real rate normalization. This isn’t panic, it’s pricing maturity in the face of persistent inflation. Consumer and business confidence remains low, yet behavior contradicts sentiment: C&I loan activity is rising Vehicle miles driven are up YoY Meanwhile, Fed officials are signaling caution, not urgency. Atlanta Fed’s Bostic favors just one rate cut in 2025, citing tariffs as stickier-than-expected inflation drivers. Jamie Dimon warns of potential stagflation and overvalued assets, though credit markets still appear complacent. Policy uncertainty persist